Latest News about Analyst Ratings
Recent news which mentions Analyst Ratings
From Benzinga
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
April 17, 2024
From Benzinga
Meta's Strategic AI Investments Enhance Ad Targeting, Boosting Revenue Projections: Analyst
April 17, 2024
From Benzinga
From Benzinga
Evaluating FB Financial: Insights From 3 Financial Analysts
April 17, 2024
Tickers
FBK
From Benzinga
From Benzinga
Election Impact: Analyst Eyes Potential Upside for Strategic Education with Republican Victory
April 17, 2024
From Benzinga
Netflix Targets Operating Margin Expansion With Growing AVOD Members And Monetization - Analyst Sees Content Innovation At Scale
April 17, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.